Haizheng Pharmaceutical Co., Ltd.: notice of approval for clinical trials of HS336 tablets

[Haizheng Pharmaceutical Co., Ltd.: notice of approval for clinical trials of HS336 tablets]-- Haizheng Pharmaceutical announced that it received a notice of approval for clinical trials of HS336 tablets. HS336 tablets are intended to be used in the treatment of advanced solid tumors.